DNA-PK—A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival

作者
Liam Cornell,Joanne M. Munck,Clara Alsinet,Augusto Villanueva,Laura Frances Ogle,Catherine E. Willoughby,Despina Televantou,Huw D. Thomas,Jennifer Jackson,Alastair D. Burt,David R. Newell,John D. Rose,Derek Manas,Geoffrey Ira Shapiro,Nicola J. Curtin,Helen Louise Reeves
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
卷期号:21 (4): 925-933 被引量:88
标识
DOI:10.1158/1078-0432.ccr-14-0842
摘要

PURPOSE: Therapy resistance and associated liver disease make hepatocellular carcinomas (HCC) difficult to treat with traditional cytotoxic therapies, whereas newer targeted approaches offer only modest survival benefit. We focused on DNA-dependent protein kinase, DNA-PKcs, encoded by PRKDC and central to DNA damage repair by nonhomologous end joining. Our aim was to explore its roles in hepatocarcinogenesis and as a novel therapeutic candidate. EXPERIMENTAL DESIGN: PRKDC was characterized in liver tissues from of 132 patients [normal liver (n = 10), cirrhotic liver (n = 13), dysplastic nodules (n = 18), HCC (n = 91)] using Affymetrix U133 Plus 2.0 and 500 K Human Mapping SNP arrays (cohort 1). In addition, we studied a case series of 45 patients with HCC undergoing diagnostic biopsy (cohort 2). Histological grading, response to treatment, and survival were correlated with DNA-PKcs quantified immunohistochemically. Parallel in vitro studies determined the impact of DNA-PK on DNA repair and response to cytotoxic therapy. RESULTS: Increased PRKDC expression in HCC was associated with amplification of its genetic locus in cohort 1. In cohort 2, elevated DNA-PKcs identified patients with treatment-resistant HCC, progressing at a median of 4.5 months compared with 16.9 months, whereas elevation of activated pDNA-PK independently predicted poorer survival. DNA-PKcs was high in HCC cell lines, where its inhibition with NU7441 potentiated irradiation and doxorubicin-induced cytotoxicity, whereas the combination suppressed HCC growth in vitro and in vivo. CONCLUSIONS: These data identify PRKDC/DNA-PKcs as a candidate driver of hepatocarcinogenesis, whose biopsy characterization at diagnosis may impact stratification of current therapies, and whose specific future targeting may overcome resistance.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
木子发布了新的文献求助10
1秒前
2秒前
不开花花发布了新的文献求助10
2秒前
黑米粥发布了新的文献求助200
2秒前
一心完成签到,获得积分10
2秒前
3秒前
所所的应助被科研通管家采纳,获得10
3秒前
Owen的应助被科研通管家采纳,获得10
3秒前
3秒前
3秒前
打打的应助被科研通管家采纳,获得10
3秒前
丘比特的应助被科研通管家采纳,获得10
4秒前
今后的应助被科研通管家采纳,获得10
4秒前
4秒前
Jun的应助被科研通管家采纳,获得10
4秒前
英姑的应助被科研通管家采纳,获得10
4秒前
4秒前
思源的应助被科研通管家采纳,获得10
4秒前
爆米花的应助被科研通管家采纳,获得10
4秒前
Orange的应助被周一采纳,获得10
5秒前
在水一方的应助被科研通管家采纳,获得10
5秒前
5秒前
NexusExplorer的应助被科研通管家采纳,获得10
5秒前
NiNi发布了新的文献求助10
5秒前
molihuakai的应助被科研通管家采纳,获得10
5秒前
今后的应助被科研通管家采纳,获得10
5秒前
所所的应助被科研通管家采纳,获得10
5秒前
学历猪八戒完成签到 ,获得积分10
5秒前
sufu_jony的应助被科研通管家采纳,获得10
5秒前
sufu_jony的应助被科研通管家采纳,获得10
5秒前
ding的应助被科研通管家采纳,获得10
6秒前
cdercder的应助被科研通管家采纳,获得10
6秒前
Owen的应助被科研通管家采纳,获得10
6秒前
OK的应助被科研通管家采纳,获得200
6秒前
白辉发布了新的文献求助10
6秒前
充电宝的应助被纯情的浩然采纳,获得10
7秒前
7秒前
7秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183880
求助须知:如何正确求助?哪些是违规求助? 9573054
关于积分的说明 21828982
捐赠科研通 7780959
什么是DOI,文献DOI怎么找? 3434134
关于科研通互助平台的介绍 2558315
邀请新用户注册赠送积分活动 2480634